Elmgreen J, Tougaard L, Leth A, Christensen M S
Eur J Clin Pharmacol. 1980 Oct;18(4):363-4. doi: 10.1007/BF00561397.
Serum concentrations of parathyroid hormone (s-PTH) calcium, phosphorus and alkaline phosphatase were measured during treatment with furosemide or bumetanide for congestive heart failure. Significant elevations both of s-PTH and alkaline phosphatase were found, whereas serum calcium concentration was decreased. The changes were not related to the dose of drug or to the duration of treatment. It is concluded that treatment with furosemide or bumetanide may cause hypocalcaemia, resulting in elevation of s-PTH. The increased concentration of alkaline phosphatase may indicate accelerated bone remodelling, as found in primary hyperparathyroidism.
在用速尿或布美他尼治疗充血性心力衰竭期间,测定了甲状旁腺激素(s-PTH)、钙、磷和碱性磷酸酶的血清浓度。发现s-PTH和碱性磷酸酶均显著升高,而血清钙浓度降低。这些变化与药物剂量或治疗持续时间无关。得出的结论是,速尿或布美他尼治疗可能导致低钙血症,从而导致s-PTH升高。碱性磷酸酶浓度升高可能表明骨重塑加速,这与原发性甲状旁腺功能亢进症中发现的情况相同。